Impact assessment of Benazir Nashonuma Programme (BNP) on maternal, child health and nutritional status in Pakistan: a quasi-experimental study protocol.
Shah Muhammad, Asma Abdul Malik, Sajid Soofi...
https://pubmed.ncbi.nlm.nih.gov/40578861Actively Recruiting
Phase Not Applicable
Age: 1Day - 59Months
All Genders
Healthy Volunteers
ID06025786
Impact Assessment of Benazir Nashonuma Program on Stunting Prevention Among Children 0-59 Months in Pakistan
Led by Aga Khan University · Updated on 2023-09-11
13200
Participants Needed
1
Research Sites
27 weeks
Total Duration
On this page
Sponsors
A
Aga Khan University
Lead Sponsor
I
International Food Policy Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the impact of the Benazir Nashonuma Program (BNP) on reducing stunting among children under five years old in low-income areas of Pakistan. The study aims to compare the prevalence of stunting and other nutritional measures in districts where BNP is active versus districts where it is not, over a four-year period. The program focuses on addressing maternal undernutrition and poor infant feeding practices, which are major causes of stunting and related health issues in children. The BNP intervention includes dietary supplements for pregnant and lactating women as well as young children, such as Maamta, a peanut butter-based supplement, and Wawamum, a nutrient-rich food for children aged 6-23 months. The program also provides conditional cash transfers to encourage antenatal care visits, institutional deliveries, child immunization, and proper nutrition practices. The study compares nine districts with BNP services to nine control districts without BNP, assessing changes from baseline to end-line. Participants include children aged 0-59 months and their mothers registered with the Benazir Income Support Program. Data collection involves household surveys in selected districts, measuring stunting rates, wasting, underweight status, breastfeeding practices, immunization coverage, maternal body mass index, and food security. The primary outcome is the change in stunting prevalence over three years. Secondary outcomes include various maternal and child nutrition and health indicators. The study will provide insights into the effectiveness of BNP in improving child growth and maternal health in Pakistan.
CONDITIONS
Brief Title
Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children
Who Can Participate
Age: 1Day - 59Months
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Child is under five years old (0-59 months)
- Child's mother is registered with the Benazir Income Support Program (BISP)
- Both mother and child are available at the time of interview
- Mother is a woman of reproductive age, between 15 and 49 years old
You will not qualify if you...
- Mother of the child is younger than 15 years or older than 49 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Intervention
Duration - Up to 3 years
Participants in intervention districts receive the Benazir Nashonuma Program (BNP), which includes dietary supplements for pregnant women, lactating mothers, and children aged 6-23 months, along with conditional cash transfers based on health and nutrition service uptake.
Periodic visits as part of routine program implementation
Follow-up
Duration - At baseline and at 3 years (on study completion)
Participants are assessed at baseline and at the end of the study to evaluate changes in stunting and other maternal and child health outcomes.
2 visits (baseline and end-line assessments)
Trial Site Locations
Total: 1 location
1
Aga Khan University
Karachi, Sindh, Pakistan, 75290
Actively Recruiting
Loading map...
Research Team
S
Sajid Bashir Soofi, MD, CPSP
S
Shah Muhammad, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here